Company intelligence / Profile preview

Infinite Brain Technology

Beijing, Beijing, Chinawjbrain.com ↗

Ownership: Private
Development stage: Phase 2

Overview

IBT has developed proprietary digital therapeutic products for neurological and mental diseases in children and adolescents. These products have undergone clinical validation through collaborations with leading hospitals and academic centers in China. The company’s solutions target improved outcomes for conditions such as ADHD and ASD using advanced AI-driven software interventions.

Therapeutic areas: Psychiatry
Modalities: Digital therapeutics (software-based interventions)Non-pharmacological therapy
Industry: Digital Health Medical Devices

Partnerships

ATLATL Innovation CentreMohamed bin Zayed University of Artificial Intelligence (MBZUAI)AffaMed TherapeuticsPeking Union Medical College HospitalBeijing Tiantan Hospital Affiliated to Capital Medical University

Beyond the preview

Go deeper on Infinite Brain Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infinite Brain Technology.

Explore the full profile